Jun 13, 2017

Leading change in Point-of-Care Testing

Estimated reading time: 3-5 minutes

We’re leading change in point-of-care testing, to benefit physicians, patients and hospital systems.

With increasing burden on healthcare systems, care providers today are under greater pressure than ever to optimize procedures, provide cost- and time-efficient care and bring care close to the patient. The benefits of point-of-care testing (POCT) have been well documented, however POCT is still not widely implemented in hospitals. In many instances, hospitals still use central laboratories to process tests, which can impact efficiency, the length of stay of a patient as well as costs.

 

As a leader in health technology, Philips aims to revolutionize healthcare management through the continuous expansion of the number of diagnostic blood tests that reach beyond the walls of laboratories. By providing advanced clinical information through meaningful, cost-efficient and connected solutions, our ambition is to bring integrated and personalized care close to the patient.

Philips minicare

Minicare I-20

In 2016, Philips launched the innovative Minicare I-20 handheld point-of-care system with cardiac troponin-l (cTnI) assay for patients with suspected Myocardial Infarction (heart attack). The system accurately measures cTnI values, near the patient in acute care settings, delivering lab comparable results within 10 minutes. Now we have reached another important milestone with the launch of next generation Minicare in-vitro diagnostics systems to facilitate timely and accurate triage decisions at the point-of-care. This will not only have a positive impact on workflow efficiency but also on quality of care to the patient, giving immediate laboratory-comparable results to support more patient-centred approaches to health care delivery.

 

Among the key innovations being showcased at EuroMedLab 2017, is the expansion of the Minicare I-20 cardiac assay panel to include Minicare BNP*, an aid in the diagnosis of heart failure (HF) in urgent and non-urgent care settings. Testing the concentrations of natriuretic peptide BNP, which are elevated in those with HF, is recommended in international guidelines to rule out non-acute HF patients.

 

In addition to Minicare BNP, I am delighted to announce the launch of two brand new Minicare family members:

 

  • Minicare H-300*, point-of-care hemostasis system to aid in the diagnosis and monitoring of coagulation abnormalities: In critical care settings, such as a heavy blood trauma or massive surgery, it can be crucial for the physician to know the accurate coagulation status of a patient. Philips will distribute a novel, point-of-care hemostasis system that can deliver real-time insights in the whole blood hemostasis status of the patient. Minicare H-300 can support and enhance the clinical decision making of the care team especially in trauma and transfusion situations.
Philips minicare h-300

Minicare H-300

  • Minicare C-300*, clinical chemistry system for an extensive range of chemistry parameters: Clinical chemistry blood tests are essential in hospital and pre-hospital settings and usually require sending blood samples to a central or external laboratory – which can be a timely process. Reflecting on this situation, Philips introduces a point-of-care clinical chemistry system as a small desktop unit allowing for rapid and efficient near-patient testing and diagnosis

 

The significant expansion of our Minicare portfolio marks a major milestone for us. We have the ambition to revolutionize the delivery of care with our Minicare platform and these exciting innovations will move diagnostics from the laboratory to where the patient is. Minicare systems realize our goal of enabling near-patient testing across the continuum of care, empowering healthcare professionals to make rapid, on-the-spot medical decisions, and ultimately improving workflow efficiency and patient outcomes.

 

*Minicare H-300, Minicare C-300 and Minicare BNP assay, are expected to become commercially available in the second half of 2017

Philips minicare 3
Philips minicare 4

About Innovation Matters

Innovation Matters delivers news, opinions and features about healthcare, and is focused on the professionals who work within the industry, as well as Philips as a cutting-edge health technology organization. From interviews with industry giants to how-to guides and features powered by Philips data, our goal is to deliver interesting, educational and entertaining content to empower and inspire all those who work in healthcare or related industries.

 

Read MoreRead Less

Share on social media

Topics

Author

Marcel van Kasteel

Marcel van Kasteel

CEO Philips Handheld Diagnostics
Follow me on